Jan/Feb 2021 • PharmaTimes Magazine • 4-5
Will the events of 2020 drive a transformation in clinical research? EB McLindon takes a look
Ana Nicholl's outlook on what this year might have in store for the sector
Oli Hudson looks at what the data tells us
so far
Paul McGrade's take on what the pharma
industry should focus on now
Patient involvement in medical
communications, by Michael Pellegrino,
SVP, Head of Scientific Services, Global
Medical Communications, ICON
Q&As with Langland's Michael Bradley
and ICON's Morgan C. Hill
42.
Appointments